Biophytis S.A. (EPA:ALBPS)
0.0542
-0.0013 (-2.34%)
At close: Feb 20, 2026
Biophytis Market Cap
Biophytis has a market cap or net worth of €1.27 million as of February 20, 2026. Its market cap has decreased by -74.58% in one year.
Market Cap
1.27M
Enterprise Value
7.74M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.05
Market Cap Chart
Since July 13, 2015, Biophytis's market cap has decreased from 45.17M to 1.27M, a decrease of -97.19%. That is a compound annual growth rate of -28.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 1.27M | -18.00% |
| Dec 31, 2025 | 1.55M | -44.45% |
| Dec 31, 2024 | 2.78M | -23.40% |
| Dec 29, 2023 | 3.64M | -51.74% |
| Dec 30, 2022 | 7.53M | -87.89% |
| Dec 31, 2021 | 62.22M | -32.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aelis Farma | 18.76M |
| GenSight Biologics | 17.95M |
| Poxel | 14.78M |
| NFL Biosciences | 14.07M |
| Plant Advanced Technologies | 9.36M |
| Oncodesign Precision Medicine Société anonyme | 9.04M |
| TME Pharma | 6.87M |
| Quantum Genomics Société Anonyme | 5.03M |